医学
慢性阻塞性肺病
气道
肺炎
哮喘
肺功能
肺结核
吸入性皮质类固醇
生活质量(医疗保健)
疾病
入射(几何)
重症监护医学
肺
内科学
外科
病理
护理部
物理
光学
作者
Rajesh Venkitakrishnan,Divya Ramachandran,Jolsana Augustine,Melcy Cleetus
标识
DOI:10.1016/j.ijtb.2021.06.010
摘要
Inhaled corticosteroids (ICS) have a central role in the management of obstructive airway diseases. Use of ICS in asthma and chronic obstructive pulmonary disease (COPD) is associated with a small but clear increase in incidence of pneumonia and tuberculosis. Since ICS use in obstructive airway diseases has beneficial effects with regard to symptoms, lung function, quality of life and exacerbations, denying the benefit of ICS solely based on this small elevated risk of pneumonias and tuberculosis is not justified. The present article attempts to elucidate mechanisms contributing to the increased risk, assesses the magnitude and risk factors of tuberculosis in patients using ICS and provides practical suggestions for practising clinicians.
科研通智能强力驱动
Strongly Powered by AbleSci AI